Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA572497
Max Phase: Preclinical
Molecular Formula: C16H15NO4
Molecular Weight: 285.30
Molecule Type: Small molecule
Associated Items:
ID: ALA572497
Max Phase: Preclinical
Molecular Formula: C16H15NO4
Molecular Weight: 285.30
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 2-Oxolycorine
Synonyms from Alternative Forms(1):
Canonical SMILES: O=C1C=C2CCN3Cc4cc5c(cc4[C@H]([C@@H]1O)[C@@H]23)OCO5
Standard InChI: InChI=1S/C16H15NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h3-5,14-16,19H,1-2,6-7H2/t14-,15+,16+/m0/s1
Standard InChI Key: HVPDCMMHMJQOAL-ARFHVFGLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 285.30 | Molecular Weight (Monoisotopic): 285.1001 | AlogP: 0.96 | #Rotatable Bonds: 0 |
Polar Surface Area: 59.00 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.00 | CX Basic pKa: 7.25 | CX LogP: 0.78 | CX LogD: 0.54 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.77 | Np Likeness Score: 1.90 |
1. Lamoral-Theys D, Andolfi A, Van Goietsenoven G, Cimmino A, Le Calvé B, Wauthoz N, Mégalizzi V, Gras T, Bruyère C, Dubois J, Mathieu V, Kornienko A, Kiss R, Evidente A.. (2009) Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight., 52 (20): [PMID:19788245] [10.1021/jm901031h] |
2. Cedrón JC, Gutiérrez D, Flores N, Ravelo AG, Estévez-Braun A.. (2010) Synthesis and antiplasmodial activity of lycorine derivatives., 18 (13): [PMID:20627737] [10.1016/j.bmc.2010.05.023] |
3. Evdokimov NM, Lamoral-Theys D, Mathieu V, Andolfi A, Frolova LV, Pelly SC, van Otterlo WA, Magedov IV, Kiss R, Evidente A, Kornienko A.. (2011) In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives., 19 (23): [PMID:22019045] [10.1016/j.bmc.2011.09.051] |
4. Nair JJ, Wilhelm A, Bonnet SL, van Staden J.. (2017) Antibacterial constituents of the plant family Amaryllidaceae., 27 (22): [PMID:29033234] [10.1016/j.bmcl.2017.09.052] |
5. Dighe SN, Ekwudu O, Dua K, Chellappan DK, Katavic PL, Collet TA.. (2019) Recent update on anti-dengue drug discovery., 176 [PMID:31128447] [10.1016/j.ejmech.2019.05.010] |
Source(1):